en

PRODUCT DETAIL

Anagrelide Vipharm 0,5 mg

Code 6810C
MA number 44/0019/18-S
Product Form: cps dur 100x0,5 mg (fľ.HDPE)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX35 Anagrelide
Shelf life: 36
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 24.01.2018
Pediatric warnings: Yes
SPC: SPC_Anagrelide Vipharm 0,5 mg_10.2022.pdf  
PIL: PIL_Anagrelide Vipharm 0,5 mg_04.2024.pdf  
Safety feature Yes
Data update: 26.07.2022
eu-flag.png sk-flag.png